Lam Research Corporation

(NASDAQ Global Select)
Somewhat Bullish +45

Buy, Hold, or Sell: Lam Research Rocketed 21% Off Its June Lows as a New Fed Begins. Is LRCX Worthwhile at $366?

📈 Lam Research shares rocketed 21% in one week to $366.81 as softer rates and a fresh Fed posture reset risk appetite across semicap.

💰 Q3 FY26 revenue hit $5.84 billion, up 23.76% year over year, with non-GAAP EPS of $1.47 against a $1.36 consensus.

🚀 June-quarter guidance calls for $6.60 billion in revenue and $1.65 in EPS, representing an unanticipated sequential acceleration.

🏭 Management upgraded the global wafer-fab equipment outlook to $140 billion as customers transition to high-density 3D NAND stacks.

📊 Operating margin expanded to 35.0% from 33.9% sequentially, with return on equity sitting at a robust 66.8%.

🔍 Barclays lifted its price target to $335 from $275, though the current price sits above this consensus level.

⚠️ Valuation concerns persist with a forward P/E of roughly 47 and trailing P/E near 69, both above five-year group averages.

🇨🇳 China generated $1.99 billion in revenue (34% of total), exposing the franchise to risks from export-control tightening.

📉 Insider activity turned net selling across seven recent transactions while free cash flow fell 20.65% year over year.

📉 The stock is up 114.53% year to date and 303.12% over the past year, significantly outperforming the S&P 500.

🎯 Analysts recommend a Hold stance as the bull thesis remains intact but the entry price has stretched relative to historical norms.

📉 A pullback into the $330 zone is identified as the technical reset that would restore reasonable risk/reward ratios.

🔮 The specific trigger for a better entry point is consolidation into the $330 zone where the forward multiple compresses toward 40.

⚡ A break above $375 on confirmed June-quarter execution would force a different conversation regarding the stock's valuation.

🛑 Chasing the stock into its 52-week high with insiders distributing is characterized as a thin edge for investors.

Bullish Signals
  • Lam Research delivered record revenue and EPS in the March quarter, driven by AI demand reshaping the semiconductor industry.
  • The company holds an entrenched position in deposition and etch tools required for high-density 3D NAND stacks and advanced packaging.
  • Operating margins expanded sequentially to 35.0%, demonstrating strong operational efficiency amidst growth.
  • Barclays lifted its price target to $335, indicating institutional confidence in the upgraded $140 billion global wafer-fab equipment outlook.
  • The stock has outperformed the broader market significantly, rising 303.12% over the past year compared to the S&P 500's 22.86% gain.
  • Management guidance for the June quarter shows sequential acceleration in both revenue and EPS, exceeding prior expectations.
Risk Factors
  • The stock trades at a forward P/E of roughly 47 and trailing P/E near 69, which are above five-year group averages and suggest high valuation.
  • China generated $1.99 billion in revenue, representing 34% of last quarter's total, which exposes the franchise to export-control tightening risks.
  • Insider activity turned net selling across seven recent transactions, potentially signaling a lack of confidence from top-level executives at current prices.
  • Free cash flow fell 20.65% year over year despite the revenue beat, indicating potential liquidity or investment pressure.
  • The stock is trading $373.82 from its 52-week peak, suggesting asymmetry has flipped and entry points are less attractive at current highs.
  • A 21% one-week move driven by macro relief rather than fresh fundamentals is a type of squeeze that often retraces before extending.
Full Analysis
Lam Research (NASDAQ: LRCX) shares surged approximately 21% in the past week to $366.81, driven by softer interest rates and a renewed risk appetite following fresh Federal Reserve commentary. The semiconductor equipment maker reported strong Q3 FY26 results with revenue of $5.84 billion, representing a 23.76% year-over-year increase. Non-GAAP earnings per share reached $1.47, beating the consensus estimate of $1.36. Management provided guidance for the June quarter expecting $6.60 billion in revenue and $1.65 in EPS, signaling sequential acceleration that exceeded market expectations. Analysts view Lam as a primary beneficiary of the AI capital expenditure boom, offering exposure to high-density 3D NAND stacks and advanced packaging without the product risks associated with chip designers. The company's global wafer-fab equipment outlook has been upgraded to $140 billion as customers transition to these new technologies where Lam holds an entrenched position. Operating margins expanded sequentially to 35.0% from 33.9%, while return on equity stands at 66.8%. Barclays recently lifted its price target to $335, reflecting confidence in the company's growth trajectory. Despite the bullish fundamentals, bears highlight valuation concerns with a forward P/E of roughly 47 and a trailing P/E near 69, both significantly above five-year averages. Concentration risk remains a factor as China accounted for approximately 34% of last quarter's revenue ($1.99 billion), exposing the franchise to potential export-control tightening. Additionally, insider activity has turned net selling across seven recent transactions, and free cash flow declined 20.65% year over year despite the top-line beat. The stock currently trades above its analyst consensus target, suggesting limited upside if the average view holds.